New Evidence of Serotonin-Deficient Depressions

In 30 patients suffering from vital depression (the syndrome of endogenous depression) a negative correlation was found between the pre-therapeutic post-probenecid CSF 5-HIAA response and the therapeutic response to clomipramine (Anafranil). Clomipramine is a tricyclic antidepressant with a strong potentiating effect on central 5-HT. The following conclusion was drawn: if the central 5-HT turnover is diminished in depressions, then correction of this biochemical disturbance leads to alleviation of depressive symptoms. This finding is considered to support the concept of ‘5-HT-deficient depression’. Five of the 8 clomipramine-resistant patients showed a favourable response to nortriptyline, a NA-potentiating anti-depressant. The pre-therapeutic CSF MHPG concentration in these patients was not related to the therapeutic efficacy of nortriptyline. So, the assumption that these patients have been NA-deficient was not confirmed. However, renal MHPG excretion was not measured and possibly this variable correlates better with cerebral NA metabolism than MHPG in lumbar CSF which is of mainly spinal origin.

[1]  M. Åsberg,et al.  "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.

[2]  H. Vanpraag.  SIGNIFICANCE OF BIOCHEMICAL PARAMETERS IN DIAGNOSIS, TREATMENT, AND PREVENTION OF DEPRESSIVE-DISORDERS , 1977 .

[3]  J. Maas.  Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. , 1975, Archives of general psychiatry.

[4]  J. Maas,et al.  Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities. , 1975, The American journal of psychiatry.

[5]  S. Takahashi,et al.  Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients. , 1975, Journal of psychiatric research.

[6]  S. Young,et al.  Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. , 1974, Brain research.

[7]  S. Snyder,et al.  Glutamic acid: selective depletion by viral induced granule cell loss in hamster cerebellum. , 1974, Brain research.

[8]  J. Schildkraut,et al.  MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized Sleep , 1973, Science.

[9]  J. Korf,et al.  Cerebral monoamines and depression. An investigation with the Probenecid technique. , 1973, Archives of general psychiatry.

[10]  J. Korf,et al.  A semiautomated fluorometric determination of 5-hydroxyindoles in the nanogram range. , 1973, Analytical biochemistry.

[11]  F. Goodwin,et al.  Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid , 1973, Science.

[12]  M. Åsberg,et al.  Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline , 1973, Clinical pharmacology and therapeutics.

[13]  J. Korf,et al.  Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. , 1971, Biochemical pharmacology.

[14]  K. Davis,et al.  Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid. , 1971, Analytical biochemistry.

[15]  T. Hökfelt,et al.  Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. , 1969, European journal of pharmacology.

[16]  T. Hökfelt,et al.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.

[17]  J. Maas,et al.  3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study. , 1968, Archives of general psychiatry.

[18]  F. Goodwin,et al.  Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. , 1975, Archives of general psychiatry.